MIRA Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $1,933,526.00
Insider Selling (Last 12 Months): $618,577.14

MIRA Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at MIRA Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MIRA Pharmaceuticals Share Price & Price History

Current Price: $0.98
Price Change: Price Decrease of -0.025 (-2.49%)
As of 03/1/2024 12:52 PM ET

This chart shows the closing price history over time for MIRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.

MIRA Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/11/2023Brian Patrick McnultyMajor ShareholderSell46,005$1.55$71,307.75660,000View SEC Filing Icon  
12/8/2023Brian Patrick McnultyMajor ShareholderSell19,053$1.61$30,675.33683,002View SEC Filing Icon  
12/6/2023Brian Patrick McnultyMajor ShareholderSell27,733$2.95$81,812.35709,196View SEC Filing Icon  
12/4/2023Brian Patrick McnultyMajor ShareholderSell61,331$3.98$244,097.38723,062View SEC Filing Icon  
11/29/2023Brian Patrick McnultyMajor ShareholderSell7,399$3.98$29,448.02756,149View SEC Filing Icon  
11/27/2023Brian Patrick McnultyMajor ShareholderSell6,425$4.00$25,700.00759,969View SEC Filing Icon  
11/20/2023Brian Patrick McnultyMajor ShareholderSell26,733$5.07$135,536.31765,681View SEC Filing Icon  
8/7/2023George CappyMajor ShareholderBuy119,048$7.00$833,336.002,859,318View SEC Filing Icon  
8/2/2023George CappyMajor ShareholderBuy157,170$7.00$1,100,190.002,740,270View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for MIRA Pharmaceuticals (NASDAQ:MIRA)

25.51% of MIRA Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

MIRA Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024GTS Securities LLC37,852$40K0.0%N/A0.256%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
MIRA Pharmaceuticals logo
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Read More on MIRA Pharmaceuticals

Today's Range

Now: $0.98
Low: $0.98
High: $1.02

50 Day Range

MA: $1.04
Low: $0.82
High: $1.36

52 Week Range

Now: $0.98
Low: $0.79
High: $7.98

Volume

8,446 shs

Average Volume

217,461 shs

Market Capitalization

$14.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of MIRA Pharmaceuticals?

MIRA Pharmaceuticals' top insider shareholders include:
  1. George Cappy (Major Shareholder)
  2. Brian Patrick Mcnulty (Major Shareholder)
Learn More about top insider investors at MIRA Pharmaceuticals.

Who are the major institutional investors of MIRA Pharmaceuticals?

MIRA Pharmaceuticals' top institutional shareholders include:
  1. GTS Securities LLC — 0.26%
Learn More about top institutional investors of MIRA Pharmaceuticals stock.

Which major investors are buying MIRA Pharmaceuticals stock?

During the last quarter, MIRA stock was purchased by institutional investors including:
  1. GTS Securities LLC
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.